DALLAS (PRWEB) November 09, 2012
Baron and Budd, a national mesothelioma law firm based in Dallas has lent its support to the National Comprehensive Cancer Network® (NCCN®) for the NCCN Guidelines for Patients®: Malignant Pleural Mesothelioma. The mesothelioma lawyers at Baron and Budd gave a sizable donation to fund the dissemination of the new resource.
The new NCCN Guidelines for Patients®: Malignant Pleural Mesothelioma translates the formal NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Malignant Pleural Mesothelioma into a patient-friendly resource. The new NCCN Guidelines for Patients®: Malignant Pleural Mesothelioma is meant to help people with mesothelioma and their families better understand the asbestos-related disease and best assess the treatment options currently available. The book of guidelines is available for free on the NCCN.org, NCCN.com, and Baron and Budd’s dedicated mesothelioma website, Mesothelioma News.
The NCCN Guidelines® are developed by multidisciplinary panels of experts from NCCN Member Institutions and feature algorithms or “decision trees” that address every appropriate management option from initial work-up throughout the course of the disease.. The NCCN Guidelines for Patients® translate these professional guidelines in a clear, step-by-step manner that people can use as the basis for making decisions and discussing treatment options with their physicians.
“As a law firm committed to helping people affected by asbestos cancers, such as mesothelioma, we know how important it is for people to fully understand their medical options just as they need to know their legal options,” said Russell Budd, president and managing shareholder of Baron and Budd and Board member of the NCCN Foundation. “We are honored to help bring such a valuable tool to mesothelioma patients.”
The mesothelioma lawyers at Baron and Budd have been dedicated to representing people impacted by mesothelioma throughout the firm’s more than 30-year history. The NCCN Guidelines for Patients®: Malignant Pleural Mesothelioma is designed to explain mesothelioma as well as offer a comprehensive list of treatment options based on a patient’s individual needs. Mesothelioma treatments include surgery, chemotherapy and radiotherapy. The guidelines also include a comprehensive step-by-step guide to malignant pleural mesothelioma treatment, covering everything from stage I to stage IV mesothelioma.
Baron and Budd was one of the first mesothelioma law firms in the United States. Baron and Budd has steadfastly fought against the asbestos companies, both in the courtroom and through charitable efforts to advocate for victims and find a cure. The firm was a cornerstone donor of the International Mesothelioma Program (IMP) at Brigham and Women’s Hospital and served on IMP’s Executive Advisory Board. Baron and Budd is also a platinum sponsor of the Asbestos Disease Awareness Organization (ADAO). The firm has also sponsored the book Understanding Mesothelioma from CURE magazine.
About Baron & Budd
The national mesothelioma law firm of Baron & Budd has a more than 30-year history of "Protecting What’s Right" for asbestos sufferers and their families. As one of the first law firms to successfully litigate an asbestos lawsuit, Baron & Budd continues to actively represent veterans, industry workers and others who are suffering as a result of exposure to asbestos. Baron & Budd achieved the largest mesothelioma verdict ever in the state of Texas, a $55 million verdict for an asbestos sufferer and his family in El Paso, Texas. Visit Baron & Budd’s dedicated mesothelioma website Mesothelioma News at http://www.mesotheliomanews.com/ or call 1.866.855.1229 for information on medical treatments, mesothelioma cancer doctors and treatment centers, high risk jobs, veterans issues and financial assistance for asbestos cancer care. http://baronandbudd.com
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.
The NCCN Member Institutions are: City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Memorial Sloan-Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/University of Tennessee Cancer Institute, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, NE; The University of Texas MD Anderson Cancer Center, Houston, TX; and Vanderbilt-Ingram Cancer Center, Nashville, TN.
Clinicians, visit NCCN.org. Patients and caregivers, visit NCCN.com.